The objective of this project is to develop isozyme-selective inhibitors against carbonic anhydrase (CA) isozymes expressed in the eye, which can lead to glaucoma.
Posting date: Thu, 03/26/2020
Award start date: Wed, 04/01/2020
Award end date: Mon, 02/28/2022